Upregulation of thyroid hormone receptor β1 and β2 messenger RNA in the myocardium of dogs with dilated cardiomyopathy or chronic valvular disease

American Journal of Veterinary Research

Volumn 60, Issue 7, 1999, Pages 848-852

  Shahrara, Shiva ^a   Tidholm, Anna ^b   Drvota, Viktor ^a   Häggstöm, Jens ^c   Sylvén, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Albano Animal Hospital of Stockholm   (Sweden)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PRIMER DNA; THYROID HORMONE RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMISTRY; CONGESTIVE CARDIOMYOPATHY; DNA PROBE; DOG; DOG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; MALE; METABOLISM; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARDIOMYOPATHY, DILATED; DNA PRIMERS; DNA PROBES; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; MALE; MITRAL VALVE INSUFFICIENCY; MYOCARDIUM; RECEPTORS, THYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033162471     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Olshausen K, Bischoff S, Kahaly G Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 1989;63:930-933.
2. Cavallo A, Joseph C, Casta A. Cardiac complications in juvenile hyperthyroidism. Am J Dis Child 1984;138:479-483.
3. Feldman T, Borow K, Same D. Myocardial mechanics in hyperthyroidism. Importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 1986;48:33-38.
4. Dillmann WH. Biochemical basis of thyroid hormone action in heart. Am J Med 1990;88:626-630.
5. Valente M, De Santo C, de Martino Rosaroll P. The direct effect of thyroid hormone on cardiac chronotropism. Arch Int Physiol Biochem 1988;97:431-435.
6. Klein I, Ojamaa K. Thyroid hormone and the heart. Am J Med 1996;101:459-460.
7. Klemperer JD, Ojamaa K, Klein I. Thyoid hormone therapy in cardiovascular disease. Prog Cardiovasc Dis 1996;38:329-334.
8. Buccino RA, Spann JF, Pool PE, et al. Influence of thyroid state on the intrinsic contractile properties and the energy stores of the myocardium. J Clin Invest 1967;46:1669-1672.
9. Rutherford JP, Vatner SF, Braunwald E. Adrenergic control of myocardial contractility in conscious hyperthyroid dogs. Am J Physiol 1980;237:590-595.
10. Magyar CE, Wang J, Azuma KK, et al. Reciprocal regulation of cardiac Na-K-ATPase and Na/Ca exchanger: hypertension, thyroid hormone, development. Am J Physiol 1995;269:675-682.
11. Limas C. Calcium transport ATPase of cardiac sarcoplasmic reticulum in experimental hyperthyroidism. Am J Physiol 1978;235: 745-751.
12. Dillmann WH. Hormonal influences on cardiac myosin ATPase activity and myosin isoenzyme distribution. Mol Cell Endocrinol 1984;34:161-181.
13. Evans RM. The steroid and thyroid hormone receptor super-family. Science 1988;240:889-895.
14. Lazar MA, Thyroid hormone receptors. Multiple forms, multiple possibilities. Endocrinol Rev 1993;14:184-193.
15. Brent G. The molecular basis of thyroid hormone action. N Engl J Med 1994;331:847-851.
16. Polikar R, Burger AG, Scherrer U, et al. The thyroid and the heart. Circulation 1993;87:1435-1441.
17. Reed R J. Acquired valvular heart disease in dogs. In: Kirk RW ed. Current veterinary therapy. Philadelphia: WB Saunders Co, 1989;231-240.
18. Fox P. Canine myocardial disease. In: Fox P, ed. Canine and feline cardiology. New York: Churchill Livingstone Inc. 1988;467-487.
19. Keene B W. Canine cardiomyopathy. In: Kirk RW, ed. Current veterinary therapy. Philadelphia: WB Saunders Co, 1989;240-251.
20. Thomas WP. Myocardial diseases of the dog. In: Bonagura JD, ed. Contemporary issues in small animal practice: cardiology. New York: Churchill Livingstone Inc, 1987;117-141.
21. Tidholm A, Jönsson L. A retrospective study of canine dilated cardiomyopathy (189 cases). J Am Anim Hosp Assoc 1996;32:465-470.
22. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Puntschart A, Wey E, Jostarndt K, et al. Expression of the fos and jun genes in human skeletal muscle after exercise. Cell Physiol 1998;274:129-137.
24. Dahlberg G. Statistical methods for medical and biological students. London: Alley G & Unwin, 1940;1-232.
25. Sylvén C, Jansson E, Sontonyi P, et al. Cardiac nuclear hormone receptor mRNA in heart failure in man. Life Sci 1996;59:1917-1922.
26. Ladenson PW, Sherman SI, Baughman KL. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci U S A 1992; 89:5251-5255.
27. Philipson KD, Edelman IS. Thyroid hormone control of Na+ K+-ATPase and K+-dependant phosphatase in the rat heart. Am J Physiol 1977;232:196-201.
28. 2+-ATPase in the rat heart. J Biol Chem 1988;263:6941-6944.
29. Winegard S, Wisenewsky C, Schwartz K. Effect of thyroid hormone on the accumulation of mRNA for skeletal and cardiac a - actin in hearts from normal and hypophysectomized rats. Proc Natl Acad Sci U S A 1990;87:2456-2462
30. Dillman WH. Cardiac function in thyroid diseases: Clinical features and management considerations. Ann Thorac Surg 1993;56: 9-15.
31. Klien I. Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631-637.
32. Rutherford JP, Vatner SF, Braunwald E. Adrenergic control of myocardial contractility in conscious dogs. Am J Physiol 1979;237: 590-596.
33. Clark JH, Schrader WT, O'Malley BW. Mechanisms of action of steroid hormones. In: Wilson JD and Foster DW, eds. William's textbook of endocrinology. 8 ed. Philadelphia: WB Saunders Co, 1992;35-90.
34. Webb P, Lopez GN, Greene GL, et al. The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol 1992; 6:157-167.
35. Kienle RD, Bruyette D, Pion PD. Effects of thyroid hormone and thyroid dysfunction on the cardiovascular system. Vet Clin North Am Small Anim Pract 1994;24:495-507.
36. Hamilton MA, Stevenson LW, Luu M, et al. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91-95.
37. Panciera DL, Refsal KR. Thyroid function in dogs with spontaneous and induced congestive heart failure. Can J Vet Res 1994;58:157-162.
38. Moruzzi P, Doria E, Agostoni PG, et al. Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol 1994;73:374-378.
39. Moruzzi P, Doria E, Agostoni PG. Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy Am J Med 1996;101:461-467.
40. Morkin E, Pennock GD, Raya TE, et al. Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure. Ann Thorac Surg 1993;56:54-60.
41. Drvota V, Brönnegård M, Häggblad J, et al. Downregulation of the thyroid hormone receptor subtype mRNA levels by amidarone during catecholamine stress in vitro. Biochem Biophys Res Commun 1995;211:991-996.
42. Klemperer JD, Zelano J, Helm RE, et al. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg 1995; 109:457-465.
43. Belshaw BE. Thyroid diseases. In: Ettinger S, ed. Textbook of veterinary internal medicine. Diseases of dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1983;1592-1614.
44. Tohgi H, Utsugisawa K, Yamagata M, et al. Effects of age on messenger RNA expression of glucocorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus. Brain Res 1995;700:245-253.